# Development of a Novel Algorithm for Real-Time Bedside Assessment of Insulin Resistance in Critically Ill Patients Based on Continuous Glucose Monitoring Data

> **NCT07385391** · — · COMPLETED · sponsor: **Chinese Medical Association** · enrollment: 179 (actual)

## Conditions studied

- Critical Illness
- Metabolism Disorders
- Insulin Resistance

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07385391
- **Lead sponsor:** Chinese Medical Association
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-07-13
- **Primary completion:** 2024-03-13
- **Final completion:** 2025-10-01
- **Target enrollment:** 179 (ACTUAL)
- **Last updated:** 2026-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07385391

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07385391, "Development of a Novel Algorithm for Real-Time Bedside Assessment of Insulin Resistance in Critically Ill Patients Based on Continuous Glucose Monitoring Data". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07385391. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*